Skip to content

Rajeev M. Shah, Director at Artiva Biotherapeutics, bought ARTV on Jun 10, 2026

Data as of Oct 16

▲ BUY$721103 shares at $7.00Rajeev M. Shah DirectorARTV Artiva Biotherapeutics, Inc.
Watch ARTV
Traded
Jun 10, 2026
Disclosed
Jun 11, 2026
Filed
1 day after the trade

Form 4s are due within two business days.

Official filing (SEC Form 4) ↗

The price around the disclosure

Rajeev M. Shah, Director at Artiva Biotherapeutics, bought ARTV on Jun 10, 2026TRADEDDISCLOSED
ARTVSimilar stocks (XLV — its sector index fund), rebased to ARTV's price on the disclosure day
ARTV since disclosure
−26.9%
Similar stocks (XLV) since disclosure
+14.7%
XLV — its sector index fund

Change in closing price from Jun 11, 2026 (the first trading day on or after disclosure) to Oct 16, 2026. Dividends excluded. Not a return anyone earned.

Our take

None of our tested rules fired on this trade.

Other trades in the same filing

  1. ▲ BUYRA Capital Nexus Fund III, L.P. DirectorARTV Artiva Biotherapeutics, Inc.$4.3Mdisclosed Jun 11 · filed the same day
  2. ▲ BUYRa Capital Management, L.P. DirectorARTV Artiva Biotherapeutics, Inc.$4.3Mdisclosed Jun 11 · filed the same day
  3. ▲ BUYRA Capital Nexus Fund, L.P. DirectorARTV Artiva Biotherapeutics, Inc.$4.3Mdisclosed Jun 11 · filed the same day
  4. ▲ BUYRA Capital Healthcare Fund LP DirectorARTV Artiva Biotherapeutics, Inc.$4.3Mdisclosed Jun 11 · filed the same day
  5. ▲ BUYRajeev M. Shah DirectorARTV Artiva Biotherapeutics, Inc.$4.3Mdisclosed Jun 11 · filed the same day
  6. ▲ BUYPeter Kolchinsky DirectorARTV Artiva Biotherapeutics, Inc.$4.3Mdisclosed Jun 11 · filed the same day
  7. ▲ BUYRA Capital Healthcare Fund LP DirectorARTV Artiva Biotherapeutics, Inc.$721disclosed Jun 11 · filed 1 day after the trade
  8. ▲ BUYRA Capital Nexus Fund, L.P. DirectorARTV Artiva Biotherapeutics, Inc.$721disclosed Jun 11 · filed 1 day after the trade
  9. ▲ BUYPeter Kolchinsky DirectorARTV Artiva Biotherapeutics, Inc.$721disclosed Jun 11 · filed 1 day after the trade
  10. ▲ BUYRA Capital Nexus Fund III, L.P. DirectorARTV Artiva Biotherapeutics, Inc.$721disclosed Jun 11 · filed 1 day after the trade
  11. ▲ BUYRa Capital Management, L.P. DirectorARTV Artiva Biotherapeutics, Inc.$721disclosed Jun 11 · filed 1 day after the trade
  12. ▲ BUYPeter Kolchinsky DirectorARTV Artiva Biotherapeutics, Inc.$3.3Mdisclosed Jun 11 · filed 2 days after the trade
  13. ▲ BUYRA Capital Nexus Fund III, L.P. DirectorARTV Artiva Biotherapeutics, Inc.$3.3Mdisclosed Jun 11 · filed 2 days after the trade
  14. ▲ BUYRa Capital Management, L.P. DirectorARTV Artiva Biotherapeutics, Inc.$3.3Mdisclosed Jun 11 · filed 2 days after the trade
  15. ▲ BUYRA Capital Nexus Fund, L.P. DirectorARTV Artiva Biotherapeutics, Inc.$3.3Mdisclosed Jun 11 · filed 2 days after the trade

See every trade on ARTV →